Heterogeneity of expression of epithelial–mesenchymal transition markers in melanocytes and melanoma cell lines

Por Kim, Ji Eun, Leung, Euphemia, Baguley, Bruce C., Finlay, Graeme J.
Publicado em 2013

Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells

Por Leung, Euphemia, Kim, Ji Eun, Rewcastle, Gordon W, Finlay, Graeme J, Baguley, Bruce C
Publicado em 2011

Evidence for the Existence of Triple-Negative Variants in the MCF-7 Breast Cancer Cell Population

Por Leung, Euphemia, Kim, Ji Eun, Askarian-Amiri, Marjan, Finlay, Graeme J., Baguley, Bruce C.
Publicado em 2014

Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer

Por Hansji, Herah, Leung, Euphemia Y., Baguley, Bruce C., Finlay, Graeme J., Askarian-Amiri, Marjan E.
Publicado em 2014

Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines

Por Leung, Euphemia Y., Askarian-Amiri, Marjan, Finlay, Graeme J., Rewcastle, Gordon W., Baguley, Bruce C.
Publicado no PLoS One (2015)

Epigenetic regulation in human melanoma: past and future

Por Sarkar, Debina, Leung, Euphemia Y, Baguley, Bruce C, Finlay, Graeme J, Askarian-Amiri, Marjan E
Publicado no Epigenetics (2015)

Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells

Por Leung, Euphemia, Rewcastle, Gordon W., Joseph, Wayne R., Rosengren, Rhonda J., Larsen, Lesley, Baguley, Bruce C.
Publicado em 2011

Relationships between Signaling Pathway Usage and Sensitivity to a Pathway Inhibitor: Examination of Trametinib Responses in Cultured Breast Cancer Lines

Por Leung, Euphemia Y., Kim, Ji Eun, Askarian-Amiri, Marjan, Rewcastle, Gordon W., Finlay, Graeme J., Baguley, Bruce C.
Publicado em 2014

Hormone Resistance in Two MCF-7 Breast Cancer Cell Lines is Associated with Reduced mTOR Signaling, Decreased Glycolysis, and Increased Sensitivity to Cytotoxic Drugs

Por Leung, Euphemia Yee, Kim, Ji Eun, Askarian-Amiri, Marjan, Joseph, Wayne R., McKeage, Mark J., Baguley, Bruce C.
Publicado em 2014

Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compound

Por Mastelić, Angela, Čikeš Čulić, Vedrana, Režić Mužinić, Nikolina, Vuica-Ross, Milena, Barker, David, Leung, Euphemia Y, Reynisson, Jóhannes, Markotić, Anita
Publicado no Drug Des Devel Ther (2017)

In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α

Por Singh, Kriti, Munuganti, Ravi Shashi Nayana, Leblanc, Eric, Lin, Yu Lun, Leung, Euphemia, Lallous, Nada, Butler, Miriam, Cherkasov, Artem, Rennie, Paul S
Publicado no Breast Cancer Res (2015)

Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative

Por Reynisson, Jóhannes, Jaiswal, Jagdish K., Barker, David, D’mello, Stacey A. N., Denny, William A., Baguley, Bruce C., Leung, Euphemia Y.
Publicado no Cancer Cell Int (2016)

ZFAS1: a long noncoding RNA associated with ribosomes in breast cancer cells

Por Hansji, Herah, Leung, Euphemia Y., Baguley, Bruce C., Finlay, Graeme J., Cameron-Smith, David, Figueiredo, Vandre C., Askarian-Amiri, Marjan E.
Publicado no Biol Direct (2016)

Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers

Por Leung, Euphemia Y., Askarian-Amiri, Marjan E., Sarkar, Debina, Ferraro-Peyret, Carole, Joseph, Wayne R., Finlay, Graeme J., Baguley, Bruce C.
Publicado no Front Oncol (2017)

Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors

Por Stones, Clare J., Kim, Ji Eun, Joseph, Wayne R., Leung, Euphemia, Marshall, Elaine S., Finlay, Graeme J., Shelling, Andrew N., Baguley, Bruce C.
Publicado em 2013

Associations between HLA Class I Alleles and Escape Mutations in the Hepatitis B Virus Core Gene in New Zealand-Resident Tongans

Por Abbott, William G. H., Tsai, Peter, Leung, Euphemia, Trevarton, Alex, Ofanoa, Malakai, Hornell, John, Gane, Edward J., Munn, Stephen R., Rodrigo, Allen G.
Publicado em 2010

Multiple Isoforms of ANRIL in Melanoma Cells: Structural Complexity Suggests Variations in Processing

Por Sarkar, Debina, Oghabian, Ali, Bodiyabadu, Pasani K., Joseph, Wayne R., Leung, Euphemia Y., Finlay, Graeme J., Baguley, Bruce C., Askarian-Amiri, Marjan E.
Publicado no Int J Mol Sci (2017)

Comparison of growth factor signalling pathway utilisation in cultured normal melanocytes and melanoma cell lines

Por Kim, Ji Eun, Stones, Clare, Joseph, Wayne R, Leung, Euphemia, Finlay, Graeme J, Shelling, Andrew N, Phillips, Wayne A, Shepherd, Peter R, Baguley, Bruce C
Publicado em 2012

Emerging Role of Long Non-Coding RNA SOX2OT in SOX2 Regulation in Breast Cancer

Por Askarian-Amiri, Marjan E., Seyfoddin, Vahid, Smart, Chanel E., Wang, Jingli, Kim, Ji Eun, Hansji, Herah, Baguley, Bruce C., Finlay, Graeme J., Leung, Euphemia Y.
Publicado em 2014

Evidence That GRIN2A Mutations in Melanoma Correlate with Decreased Survival

Por D’mello, Stacey Ann N., Flanagan, Jack U., Green, Taryn N., Leung, Euphemia Y., Askarian-Amiri, Marjan E., Joseph, Wayne R., McCrystal, Michael R., Isaacs, Richard J., Shaw, James H. F., Furneaux, Christopher E., During, Matthew J., Finlay, Graeme J., Baguley, Bruce C., Kalev-Zylinska, Maggie L.
Publicado em 2014